Another under-the-radar stock Cramer highlighted was Shutterstock, the online marketplace for high quality photos, videos, illustrations and music. In an increasingly digital world, Shutterstock makes it easy to create the imagery many companies are looking for.
The stock lost almost half its value last year among the growth sell-off. However, the Shutterstock has been on the rebound, bouncing back 25 percent for the year.
The company's chairman and CEO commented on the rapid growth of the company, stating "We have 1.5 million customers. They are businesses of all sizes that use our images to sell their products and services. That equates to selling five images every single second."
One stock that delivered an outstanding quarter was International Flavors & Fragrances, ticker IFF. It is one of the leading suppliers of flavors and fragrances for food, beverage, personal care and household products.
"I like the describe IFF as a stealth technology company. It may seem frivolous, but what these guys do is all about science," Cramer said.
IFF invents proprietary compounds with a specific taste or scent, and then licenses the compound out to the food, beverage and consumer packaged goods industry. After the quarter it delivered, it was clear to Cramer that if the dollar continues to weaken, IFF will gain a strong tailwind that could push the stock higher.
Cramer spoke with IFF CEO Andreas Fibig on the broad range of the company's products.
"I would say we are in the business of art and science. That describes us very, very well. Many of our perfumes create all of these wonderful fragrances and all the wonderful tastes that you can basically taste in every ice cream or beverage you drink," Fibig said.
In the Lightning Round, Cramer gave his take on a few caller favorite stocks:
Seagate Technology: "Maybe a classic value trap. I have now started to worry about the dividend coverage even though it's a well-run company. They have not diversified away from the P.C. and we know what's going on with the P.C."
AbbVie: "Oh man they are good. I'm going to give you a two-for, I like both Abbott and AbbVie, they are really well-run companies. A lot of valuation created there."